\n| 15:30 \u2013 15:40<\/td>\n | Welcome by IBM<\/b> \n \nFranziska Reist \nConsulting Leader and Member of the Board, \nIBM Switzerland<\/i><\/td>\n<\/tr>\n\n| 15:40 \u2013 16:00<\/td>\n | The promises of Digital Therapeutics<\/b> \n \nJ\u00F6rg H\u00F6lzing \nSVP, Global Head of Strategy & Customer Solutions, \nRoche<\/i><\/td>\n<\/tr>\n\n| 16:00 \u2013 16:20<\/td>\n | Precision Medicine \u2013 how to make it happen<\/b> \n \nMichel van Speybroeck \nHead of EMEA Data Sciences, Real World Evidence, \nJanssen Pharmaceutical Companies of J&J<\/i> \n \nTahera Kan \nSenior Director Global Business Development, \nJanssen Pharmaceutical Companies of J&J<\/i><\/td>\n<\/tr>\n\n| 16:20 \u2013 16:40<\/td>\n | Recognizing the potential of precision medicine and image recognition in ophthalmology<\/b> \n \nVictor Chong \nGlobal Head of Ophthalmology, \nBoehringer Ingelheim<\/i><\/td>\n<\/tr>\n\n| 16:40 \u2013 17:00<\/td>\n | Break<\/b><\/td>\n<\/tr>\n\n| 17:00 \u2013 17:20<\/td>\n | Leveraging Real World Evidence to improve clinical studies<\/b> \n \nMichael Seewald \nVP & Global Head, Real World Evidence, \nNovartis<\/i> \n \nMelvin Olson \nGlobal Head of RWD Strategy and Innovation, \nNovartis<\/i><\/td>\n<\/tr>\n\n| 17:20 \u2013 17:40<\/td>\n | How to empower patients through symptom reporting and virtual coaching to manage disease and lifestyle?<\/b> \n \nThomas Brunschwiler \nResearch Staff Member, \nIBM Research<\/i><\/td>\n<\/tr>\n\n| 17:40 \u2013 19:00<\/td>\n | Closing Remarks & Ap\u00E9ro Riche<\/b><\/td>\n<\/tr>\n","locSectionTitle":"Location","AGID":"8AC67265DD6B1CBF852583E7002D8FF0","includeAgenda":"Yes"},"isEnglish":true,"mobileSpecs": {"blackBerry":false,"iPhone":false,"iPad":false,"webOS":false,"android":false,"client":"ArchiveTeam ArchiveBot\/20191207.38f77ff (wpull 2.0.3) and not Mozilla\/5.0 (Windows NT 6.1; WOW64) AppleWebKit\/537.36 (KHTML, like Gecko) Chrome\/42.0.2311.90 Safari\/537.36","isSmall":false,"isMobile":false,"windowsPhone":false,"iPod":false},"usoapNoGoeFlag":"","qs":"?openform&seminar=QZ3GC6OE&locale=en_ZZ&auth=anonymous","form": {"fieldSpecs":null,"formSpecs":null,"formNames":false},"userid":"","userFullName":"Anonymous","doc": {"unid":"E2276AD27AF0B34F852585FF000F57EB"},"client": {"clientType":"ArchiveTeam ArchiveBot\/20191207.38f77ff (wpull 2.0.3) and not Mozilla\/5.0 (Windows NT 6.1; WOW64) AppleWebKit\/537.36 (KHTML, like Gecko) Chrome\/42.0.2311.90 Safari\/537.36","mobile": {"blackBerry":false,"iPhone":false,"iPad":false,"webOS":false,"android":false,"client":"ArchiveTeam ArchiveBot\/20191207.38f77ff (wpull 2.0.3) and not Mozilla\/5.0 (Windows NT 6.1; WOW64) AppleWebKit\/537.36 (KHTML, like Gecko) Chrome\/42.0.2311.90 Safari\/537.36","isSmall":false,"isMobile":false,"windowsPhone":false,"iPod":false},"isSmall":false,"isMobile":false,"useStyledForm":true},"isMobile":false,"baseURL":"\/events\/wwe\/grp\/grp312.nsf"}Event Flyer
Life Sciences Dialogue is a platform to be inspired by forward thinking senior business leaders from the Life Sciences and Healthcare industry. This event creates ecosystem opportunities beyond traditional boundaries. This year we focus on the impact of digital on the development of medication and the way therapies are provided. We are seeing this converging to a new era of transactions within the Healthcare and Life Sciences industry.
In the center of Basel, you will be inspired by crisp 20 minute speed presentations from senior industry leaders in the area of precision medicine and digital therapeutics. You will create new connections, exchange experiences and carry on these ideas to your businesses. Markthallen Basel
Steinentorberg 20
CH-4051 Basel
Directions IBM Life Sciences Dialogue 2019, 5th of June 2019| Description & Speaker |
|---|
| 15:30 – 15:40 |
Welcome by IBM
Franziska Reist
Consulting Leader and Member of the Board,
IBM Switzerland |
| 15:40 – 16:00 |
The promises of Digital Therapeutics
Jörg Hölzing
SVP, Global Head of Strategy & Customer Solutions,
Roche |
| 16:00 – 16:20 |
Precision Medicine – how to make it happen
Michel van Speybroeck
Head of EMEA Data Sciences, Real World Evidence,
Janssen Pharmaceutical Companies of J&J
Tahera Kan
Senior Director Global Business Development,
Janssen Pharmaceutical Companies of J&J |
| 16:20 – 16:40 |
Recognizing the potential of precision medicine and image recognition in ophthalmology
Victor Chong
Global Head of Ophthalmology,
Boehringer Ingelheim |
| 16:40 – 17:00 |
Break |
| 17:00 – 17:20 |
Leveraging Real World Evidence to improve clinical studies
Michael Seewald
VP & Global Head, Real World Evidence,
Novartis
Melvin Olson
Global Head of RWD Strategy and Innovation,
Novartis |
| 17:20 – 17:40 |
How to empower patients through symptom reporting and virtual coaching to manage disease and lifestyle?
Thomas Brunschwiler
Research Staff Member,
IBM Research |
| 17:40 – 19:00 |
Closing Remarks & Apéro Riche |
| | | | | | | |